Background: Diagnosing Alzheimer’s disease (AD) in the preclinical stage offers opportunities to early intervention, however, there is a lack of convenient biomarkers currently. By using the methods of radiomics analysis, we aimed to determine whether the features extracted from multi-parameter magnetic resonance imaging (MRI) can be used as potential biomarkers. Methods: This study is part of the SILCODE project (NCT03370744). All participants were cognitively healthy at baseline. The cohort 1 (n=183) was divided into individuals with preclinical AD (n=78) and controls (n=105) by amyloid-positron emission tomography, used as the training dataset (80%) and validation dataset (the rest 20%); cohort 2 (n=51) was divided into “converters” and “non-converters” by individuals’ future cognitive status, used as a separate test dataset; cohort 3 included 37 “converters” (13 from ADNI), was used as another test set for independent longitudinal researches. We extracted radiomics features from multi-parameter MRI of each participant, used t-tests, autocorrelation tests, and three independent selection algorithms, respectively, to select features. Then we established two classification models (support vector machine (SVM) and random forest (RF)) to verify the efficiency of retained features. Five-fold cross-validation and 100 repetitions were carried out for the above process. Furthermore, the acquired stable high-frequency features were tested in cohort 3 by paired two-sample t-tests and survival analyses, in order to identify whether their levels change with cognitive decline and impact conversion time. Results: The SVM and RF models both showed excellent classification efficiency, with the average accuracy of 89.65%-95.90% and 87.07%-90.81% respectively in the validation set, 81.86%-89.10% and 83.19%-83.68% respectively in the test set. Three stable high-frequency features were identified, namely Large zone high-gray-level emphasis feature of right posterior cingulate gyrus, Variance feature of left superior parietal gyrus and Coarseness feature of left posterior cingulate gyrus, all based on structural MRI modality; their levels were correlated with amyloid-β deposition, played good roles in predicting future cognitive decline (AUCs 64.9%-76.1%). In addition, levels of the Variance feature at baseline timepoint decreased with cognitive decline, and can affect the conversion time (p<0.05). Conclusion: In this exploratory study, we show radiomics features of multi-parameter MRI can be potential biomarkers of preclinical AD.